首页> 美国卫生研究院文献>Journal of Virology >Note: Coreceptor Utilization by Human Immunodeficiency Virus Type 1 Is Not a Primary Determinant of Neutralization Sensitivity
【2h】

Note: Coreceptor Utilization by Human Immunodeficiency Virus Type 1 Is Not a Primary Determinant of Neutralization Sensitivity

机译:注意:1型人类免疫缺陷病毒对共受体的利用不是中和敏感性的主要决定因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have examined the relationship between coreceptor utilization and sensitivity to neutralization in a primary isolate of human immunodeficiency virus type 1 and its T-cell line-adapted (TCLA) derivative. We determined that adaptation of the primary-isolate (PI) virus 168P results in the loss of the unique capacity of PI viruses to utilize the CCR5 coreceptor and in the acquisition by the TCLA 168C virus of sensitivity to neutralization by V3-directed monoclonal antibodies (MAbs). In experiments wherein infection by 168P is directed via either the CCR5 or the CXCR4 pathway, we demonstrate that the virus, as well as pseudotyped virions bearing a molecularly cloned 168P envelope protein, remains refractory to neutralization by MAbs 257-D, 268-D, and 50.1 regardless of the coreceptor utilized. This study suggests that coreceptor utilization is not a primary determinant of differential neutralization sensitivity in PI and TCLA viruses.
机译:我们已经检查了人类免疫缺陷病毒1型及其T细胞系适应性(TCLA)衍生物的主要分离物中共受体利用与中和敏感性之间的关系。我们确定,对主要隔离(PI)病毒168P的适应导致PI病毒利用CCR5核心受体的独特能力的丧失以及TCLA 168C病毒对V3定向单克隆抗体中和的敏感性的获得(单克隆抗体)。在通过CCR5或CXCR4途径直接感染168P的实验中,我们证明了该病毒以及带有分子克隆的168P包膜蛋白的假型病毒体,仍然对MAb 257-D,268-D的中和作用具有抵抗力,和50.1无关,无论所使用的共受体。这项研究表明,在PI和TCLA病毒中,共受体的利用不是差异中和敏感性的主要决定因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号